Back to VANGUARD GROUP INC VANGUARD GROUP INC

INOINO
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in INOVIO PHARMACEUTICALS INC

As of its last 13F, for Q4 2025, Vanguard Group held 3,315,580 shares of INO (Inovio Pharmaceuticals), worth $5.8M. It increased the position by 602,708 shares (+22.2%) from Q3 2025. Vanguard Group held INO from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$5.8M

Current Shares

3.3M

Total Value Change

-$4.6M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
3.3M
+22.2%
$5.8M0.0%$1.74
33
2025-Q3
Increased
2.7M
+35.0%
$6.3M0.0%$2.34
35
2025-Q2
Decreased
2M
-1.0%
$4.1M0.0%$2.04
0
2025-Q1
Increased
2M
+21.2%
$3.3M0.0%$1.63
32
2024-Q4
Decreased
1.7M
-6.9%
$3.1M0.0%$1.83
0
2024-Q3
First report
1.8M
-
$10.4M0.0%$5.78
0

Other major holders of INO: FMR LLC, BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used